| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 102,370 | 89,257 | 106,890 | 140,170 | | Cost of Revenue | 67,741 | 59,281 | 73,194 | 111,458 | | | Gross Profit | 34,629 | 29,976 | 33,696 | 28,712 | | | Operating Expenses | | Research Development | 10,659 | 11,793 | 11,465 | 12,034 | | Selling General and Administrative | 25,529 | 25,694 | 28,763 | 38,823 | | Non Recurring |
-
|
-
| 38,044 | 252,283 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,559) | (7,511) | (44,576) | (274,428) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,120 | (5,869) | 462 | 4,421 | | Earnings Before Interest And Taxes | 561 | (13,380) | (44,114) | (270,007) | | Interest Expense | 6,380 | 6,861 | 7,417 | 9,992 | | Income Before Tax | (5,819) | (20,241) | (51,531) | (279,999) | | Income Tax Expense | 131 | (4,510) | (13,963) | (8,212) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,950) | (15,731) | (37,568) | (271,787) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,950) | (15,731) | (37,568) | (271,787) | | Preferred Stock And Other Adjustments | (875) | (875) | (875) | (69,932) | | | Net Income Applicable To Common Shares | ($6,825) | ($16,606) | ($38,443) | ($341,719) |
|
0.03% Nasdaq 
0.07 (1.13%) 
Income Statement
